We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Tianjin Medical University Cancer Institute and Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01678170
First Posted: September 3, 2012
Last Update Posted: December 22, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital
  Purpose
This trial is going to evaluate the value of blood-oxygen functional imaging technology in the diagnosis of breast diseases.

Condition
Breast Diseases

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical Application of Breast Blood-oxygen Functional Imaging Technology

Resource links provided by NLM:


Further study details as provided by Tianjin Medical University Cancer Institute and Hospital:

Estimated Enrollment: 200
Study Start Date: September 2012
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Female with breast lump, received breast ultrasound and mammography
Criteria

Inclusion Criteria:

  • female older than 18 years breast lump received breast ultrasound and mammography

Exclusion Criteria:

  • After core-needle biopsy or resection After neoadjuvant chemotherapy, radiotherapy or endocrine therapy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678170


Contacts
Contact: Peifang Liu, M.D. +86-22-23524536 cjr.liupeifang@vip.163.com

Locations
China, Tianjin
Department of Breast Imaging, Tianjin Medical University Cancer Hospital Recruiting
Tianjin, Tianjin, China, 300060
Contact: Peifang Liu, M.D.    +86-22-23524536    cjr.liupeifang@vip.163.com   
Sponsors and Collaborators
Tianjin Medical University Cancer Institute and Hospital
Investigators
Principal Investigator: Peifang Liu, M.D. Department of Breast Imaging, Tianjin Medical University Cancer Hospital
  More Information

Responsible Party: Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov Identifier: NCT01678170     History of Changes
Other Study ID Numbers: CIH-LPF-201205001
First Submitted: August 30, 2012
First Posted: September 3, 2012
Last Update Posted: December 22, 2015
Last Verified: May 2012

Keywords provided by Tianjin Medical University Cancer Institute and Hospital:
blood-oxygen functional imaging technology
diagnosis

Additional relevant MeSH terms:
Breast Diseases
Skin Diseases